|
|
|
Location: Home -
Products - Reference Compounds&Impurities - Reference Compounds
|
BI-D1870
Catalogue No. : |
C16292 |
Product Name: |
BI-D1870 |
Synonym: |
BI-D 1870;p90 Ribosomal S6 Kinase Inhibitor II |
Chemical Name: |
2-(3,5-Difluoro-4-hydroxy-anilino)-8-isopentyl-5,7-dimethyl-7H-pteridin-6-one, racemic |
CAS No. : |
501437-28-1 |
Structure : |
|
Molecular Formula: |
C19H23F2N5O2 |
Molecular Weight: |
391.42 |
Purity: |
>98% |
Usage: |
BI-D1870 is a potent and specific inhibitor of the p90 ribosomal S6 kinase (RSK) isoforms in vitro and in vivo, which inhibits RSK1, RSK2, RSK3 and RSK4 in vitro with an IC50 of 10-30 nM (IC50 at 100 μM ATP: RSK1 = 31 nM, RSK2 = 24 nM, RSK3 = 18 nM, RSK4 = 15 nM). BI-D1870 does not significantly inhibit ten other AGC kinase members and over 40 other protein kinases tested at 100-fold higher concentrations. BI-D1870 does not affect the agonist-triggered phosphorylation of substrates for six other AGC kinases. Additionally, BI-D1870 does not suppress the phorbol ester- or EGF-induced phosphorylation of CREB (cAMP-response-element-binding protein). |
|
Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. As it is impossible for us to be informed about the patent situation in all countries, the liability for patent infringement is exclusively to be understood as buyer's risk. |
|
|